Julia C. Rosebush to HIV Infections
This is a "connection" page, showing publications Julia C. Rosebush has written about HIV Infections.
Connection Strength
1.232
-
Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2021 03 01; 35(3):419-427.
Score: 0.399
-
Increased Immune Activation and Exhaustion in HIV-infected Youth. Pediatr Infect Dis J. 2016 12; 35(12):e370-e377.
Score: 0.297
-
Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther. 2018; 23(4):315-324.
Score: 0.080
-
Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth. J Acquir Immune Defic Syndr. 2017 12 15; 76(5):539-546.
Score: 0.080
-
Effects of vitamin D supplementation on carotid intima-media thickness in HIV-infected youth. Virulence. 2018 01 01; 9(1):294-305.
Score: 0.079
-
Arterial stiffness in HIV-infected youth and associations with HIV-related variables. Virulence. 2017 10 03; 8(7):1265-1273.
Score: 0.076
-
Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth. J Steroid Biochem Mol Biol. 2017 04; 168:38-48.
Score: 0.075
-
Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation. Antivir Ther. 2017; 22(8):669-680.
Score: 0.075
-
Efavirenz and ritonavir-boosted lopinavir use exhibited elevated markers of atherosclerosis across age groups in people living with HIV in Ethiopia. J Biomech. 2016 09 06; 49(13):2584-2592.
Score: 0.072